| 000 | 01028nam a22002897a 4500 | ||
|---|---|---|---|
| 001 | D0001B000103 | ||
| 005 | 20201216141439.0 | ||
| 008 | 201216b ||||| |||| 00| 0 eng d | ||
| 040 | _erda | ||
| 245 | 0 | 0 |
_aHow to investigate drug use in communities : _bguidelines for social science research / _cAnita Hardon, Pascale Brudon-Jakobowicz, Anne Reeler |
| 260 |
_aGeneva : _bWHO, _c1992. |
||
| 300 | _a43 pages. | ||
| 336 |
_2rdacontent _atext |
||
| 337 |
_2rdamedia _aunmediated |
||
| 338 |
_2rdacarier _avolume |
||
| 490 |
_aDAP research series ; _vno. 2 |
||
| 650 | 2 | _aCommunity Health Services | |
| 650 | 2 | _aDrug Utilization | |
| 650 | 2 | _aPharmaceutical Preparations | |
| 650 | 2 | _aResearch | |
| 700 | 1 | _aHardon, Anita | |
| 700 | 1 | _aBrudon-Jakobowicz, Pascale | |
| 700 | 1 | _aReeler, Anne | |
| 710 | 2 |
_aWorld Health Organization. _bAction Programme on Essential Drugs and Vaccines |
|
| 856 | _uhttps://apps.who.int/iris/bitstream/handle/10665/61866/WHO_DAP_92.3.pdf?sequence=1&isAllowed=y | ||
| 942 |
_cBK _2ddc |
||
| 999 |
_c2081 _d2081 |
||